METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare's Nomination and Remuneration Committee has approved two items. First, the allotment of 4,200 equity shares to employees who exercised their Restrictive Stock Units (RSUs) under the MHL-RSU Plan, 2020 at an exercise price of just INR 2 per share. Second, the company granted 14,236 RSUs under the Metropolis-RSU Plan, 2025 and 212,345 stock options under the Metropolis-Employees Stock Options Plan, 2025. The RSUs have an exercise price of INR 2 (face value), while the stock options have an exercise price of INR 375.62 per option. All awards have a vesting period of 1 to 4 years with an exercise window of up to 5 years after vesting.
This is a routine employee compensation disclosure that will result in modest dilution of approximately 0.002% of total shares. The significant discount on RSUs (INR 2 vs. market price) represents a compensation expense that may slightly impact earnings per share, but is generally viewed positively as it aligns employee and shareholder interests.